Researchers can obtain stem cells that NIH Center for Alzheimer’s and Related Dementias (CARD) scientists have specially engineered for studying the genes behind Alzheimer’s disease several other neurodegenerative disorders.
During the July 25 meeting of the Advisory Council on Alzheimer’s Research, Care, and Services, NIA Director Richard J. Hodes, M.D., unveiled NIH’s FY 2024 Professional Judgment Budget for Alzheimer’s Disease and Related Dementias.
Scientists discovered a specific protein in young mice CSF that may help improve memory and provide a new therapeutic target for treating age-related memory loss and neurodegenerative disorders.